Comparative of the effect of oral isotretinoin and desloratadine with oral isotretinoin in the treatment of moderate to severe acne vulgaris patients
Phase 3
- Conditions
- Acne vulgaris.Acne vulgarisL70.0
- Registration Number
- IRCT20220705055374N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patient with moderate to severe acne
Exclusion Criteria
Age<18 years
Pregnant and lactating female
Systemic disease
Concurrent use of other acne therapies
Other dermatological condition requiring interfering treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method